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in the LGN of mice lacking C1q or C3 is 
remarkably similar to that seen in mice 
deficient for cell surface MHC class I (A. 
Datwani and C.J. Shatz, personal com-
munication). Thus, it is possible that 
C1q and C3 act by inducing expression 
of MHC class I in the developing visual 
system. Future work might resolve 
this question by determining whether 
MHC class I levels are reduced in mice 
lacking C1q or C3 (or vice versa) and 
assessing whether the effects of MHC 
class I deficiency and C1q deficiency 
on visual system development occlude 
one another, which would suggest that 
they act in functionally convergent 
pathways.
Activated microglia are the only 
cells of the brain known to express 
C3 receptors (Gasque et al., 1998), 
indicating that they may participate 
in synaptic remodeling mediated by 
C3 (Figure 1). If microglia contribute 
to this process, one prediction is that 
higher numbers of microglia should 
be present in the developing brain 
specifically during the period of active 
remodeling. This is in fact the case in 
some brain regions (e.g., Maslinska et 
al., 1998). High numbers of activated 
microglia have also recently been 
reported in postmortem brain sam-
ples from patients with autism (Vargas 
et al., 2005), raising the possibility that 
microglia might contribute to patho-
logical changes in connectivity in this 
neurodevelopmental disorder.
The results reported by Stevens et 
al. add to growing evidence that the 
immune system and nervous sys-
tem make different use of some of 
the same molecular machinery. This 
molecular overlap could act as a point 
of either beneficial or harmful cross-
talk between the two systems in injury 
and disease states and hints at new 
therapeutic directions for a wide vari-
ety of neurological disorders. Much 
additional work is needed to elucidate 
the precise molecular mechanisms by 
which proteins of the innate and adap-
tive immune system also participate in 
normal brain development and plastic-
ity. Fortunately, this work will be greatly 
facilitated by the knowledge and exper-
imental tools established when these 
proteins were first characterized in the 
immune system.
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Malaria parasites must invade the erythrocytes of its host, to be able to grow and multiply. 
Having depleted the host cell of its nutrients, the parasites break out to invade new eryth-
rocytes. In this issue of Cell, Yeoh et al. (2007) discover a new organelle, the exoneme, that 
contains a protease SUB1, which helps the parasite to escape from old erythrocytes and 
invade new ones.The malaria parasite (Plasmodium) 
is a unicellular, obligate intracellular 
protozoan that must invade, colonize, 
replicate within, and emerge from 
various cells types of the mamma-1036 Cell 131, December 14, 2007 ©200lian host or mosquito vector in order 
to complete its life cycle. Although 
the basic structure of Plasmodium is 
comparable to a standard eukaryotic 
cell, it is capable of producing dis-7 Elsevier Inc.tinct invasive forms and specialized 
organelles that are evolved to recog-
nize and invade the correct cell type. 
For growth and multiplication in the 
bloodstream of its vertebrate host, 
figure 1. The Blood stage in the Life cycle of the Malaria Parasite
Propagation of malaria parasites in the blood begins with invasion of an erythrocyte by a merozoite from an infected liver cell or from a previously 
infected erythrocyte. For invasion, the merozoite uses three organelles: rhoptries, micronemes, and dense granules that are involved in merozoite 
attachment, reorientation, invasion, and formation of the vacuole in which the parasite grows (the parasitophorous vacuole). Now, Yeoh et al. (2007) 
reveal the presence of a new organelle, the exoneme, that is involved in the release of merozoites from the old erythrocyte. These organelles contain 
the protease SUB1 that play a key role in activating the host SERA proteases that are associated with destruction of the parasitophorous vacuole 
and the erythrocyte membrane. In addition to preventing egress of merozoites, an inhibitor of SUB1 also prevents merozoite invasion of the eryth-
rocyte, indicating that SUB1 may also promote the maturation of malarial proteins that are involved in invasion.the malaria parasite is dependent 
on erythrocytes, which it invades 
and inhabits for 24–72 hr, consum-
ing hemoglobin and forming 8–32 
“daughters” or merozoites (Figure 1). 
For further survival, these merozoites 
leave the old, depleted erythrocyte 
and find a new erythrocyte (Figure 
1). Yeoh et al. (2007) provide impor-
tant new insights into how merozo-
ites make their escape from depleted 
erythrocytes.
The recognition and invasion of new 
erythrocytes by the malarial merozo-
ite has been well-studied (reviewed in 
Crabb and Cowman, 2006). The inva-
sive forms of this and other related 
parasites are defined by the presence 
of an apical complex of organelles—
hence their grouping into the phylum 
Apicomplexa—that are associated 
with the invasion processes. Electron 
micrographs have revealed the fine 
ultrastructural detail of all invasive 
forms of Plasmodium. In merozoites, 
the apical complex contains three 
typical, distinct organelles identified 
by shape, protein content, and func-
tion: a pair of rhoptries, numerous 
micronemes, and approximately 50 
dense granules (Figure 1). Although 
the functions of the three organelles 
overlap, in general rhoptries contain proteins essential for parasite recogni-
tion and invasion of the host cell—par-
ticularly in the merozoite invading the 
erythrocyte—and also lipid stocks that 
help establish the parasitophorous 
vacuole that the colonizing parasite 
must establish around itself (reviewed 
in Kats et al., 2006). Micronemes con-
tain additional adhesins used to iden-
tify and attach to the target host cell 
and to link to actomyosin filaments 
for gliding and invasion (reviewed in 
Dowse and Soldati, 2004). Dense gran-
ules contain proteins that establish the 
lines of communication between the 
parasitophorous vacuole membrane 
and the host cell and beyond (reviewed 
in Mercier et al., 2005).
Blackman and colleagues (Yeoh et 
al., 2007) now demonstrate that mero-
zoites have not only developed spe-
cific organelles for invasion of eryth-
rocytes but also for egress from these 
cells. They show that the dense gran-
ules of the apical complex are more 
heterogeneous than previously rec-
ognized and that their protein content 
and function can be sufficiently dis-
tinct to identify new organelles within 
their midst. Welcome the exoneme to 
our lexicon. The identification of the 
exoneme stemmed from the group’s 
long-standing interest in the role of Cell 131, Deceproteases in merozoite egress from 
the infected erythrocyte and eryth-
rocyte invasion. Studies with broad-
range protease inhibitors had revealed 
the crucial nature of numerous (serine 
and papain-like) protease activities for 
several merozoite-associated events 
coupled to both erythrocyte invasion 
and merozoite release upon rupture 
of the infected erythrocyte (Delplace 
et al.,1988; Wickham et al., 2003). 
Focusing on merozoite release, it is in 
principle at least a two-step process 
as two membranes, the parasito-
phorous vacuole membrane and the 
infected erythrocyte membrane, must 
be ruptured in order to secure mero-
zoite release. Of the three subtilisin-
like serine proteases encoded in the 
conserved Plasmodium genome, one 
(termed SUB1) possessed an expres-
sion profile consistent with a role in 
parasite egress, that is it’s expres-
sion peaks at schizont maturity (the 
schizont is the form of the parasite in 
infected erythrocytes that contains 
fully mature daughter merozoites). 
Blackman’s group had previously 
characterized SUB1 from the lethal 
human parasite Plasmodium falci-
parum (PfSUB1) and demonstrated its 
distinctive structural properties that 
make it a promising target for drug mber 14, 2007 ©2007 Elsevier Inc. 1037
development (Withers-Martinez et al., 
2002). In the current study, Yeoh et al. 
(2007) show that pfsub1 is an essen-
tial gene. The authors engineered a 
C-terminal epitope HA-tagged ver-
sion of PfSUB1 (PfSUB1HA3) to fol-
low its localization. They noticed that 
PfSUB1HA3 localizes to an apical 
disposed structure that resembled 
a dense granule but did not colocal-
ize with a marker of dense granules 
such as the ring-infected erythrocyte 
surface antigen RESA. Furthermore, 
although RESA and other proteins 
are found in newly infected erythro-
cytes, PfSUB1HA3 was not. In fact, 
PfSUB1HA3 could be found only in 
supernatants of ruptured schizont cul-
tures, implying that the PfSUB1HA3 
granule was released significantly 
earlier than the RESA-dense granule 
and immediately prior to rupture of 
the mature schizont. Through screens 
using recombinant PfSUB1HA3, the 
authors isolated an inhibitor of this 
enzyme. Using this inhibitor, Yeoh et al. 
show that PfSUB1 activity is required 
for schizont rupture and erythrocyte 
reinvasion. They also show that sch-
izont rupture and erythrocyte reinva-
sion is associated with the processing 
of an essential papain-like protease 
SERA5 (Miller et al., 2003) by PfSUB1 
immediately prior to merozoite egress. 
Subsequent experiments confirmed 
SERA5 and other important SERA 
family members (4 and 6) that are 
expressed during schizogony as 
physiological substrates for PfSUB1.
This study provides the first major 
insight into the molecular mecha-
nisms associated with merozoite 
egress from the infected eryth-
rocyte. PfSUB1 activity is initially 
housed within the exoneme and is 
then released into the milieu of the 
parasitophorous vacuole where it 
digests and activates the papain-
like proteases SERA4-6. The SERA 
proteases in turn play a role in the 
subsequent destruction of the para-
sitophorous vacuole and possibly the 
infected erythrocyte membrane itself 
thereby releasing the invading hordes 
of merozoites. These results support 
the “inside-out” model of membrane 
destruction during egress (Wickham 
et al., 2003). One relevant insight is 1038 Cell 131, December 14, 2007 ©200that merozoite egress is a process 
controlled through the release of fac-
tors by the merozoite itself. Egress 
requires more cellular events than 
a simple activation signal originat-
ing within the lumen of the parasito-
phorous vacuole and is thus poten-
tially more highly regulated. This is 
important because for infection to 
be maintained, egress requires that 
merozoite formation within the synci-
tium of the parasitophorous vacuole is 
a highly coordinated process (which 
it is) otherwise one or two merozoites 
racing ahead to maturity could trig-
ger release of suboptimal numbers of 
fully mature parasites.
These are fascinating insights but 
like all new observations raise a host 
of additional questions some of which 
the authors also discuss. Dense gran-
ules should no longer be thought of 
as homogeneous, but are there only 
two classes—exonemes and “classic” 
dense granules—or are further subdi-
visions based on protein content and 
function possible for dense granules, 
rhoptries, and micronemes? How are 
proteins trafficked to the two different 
granule classes; do the signals overlap 
or are they completely different? Does 
SUB1 play a direct role in destroying 
parasitophorous vacuole and infected 
erythrocyte membranes, rather than 
merely activating the destroyers as 
is implied though not strictly proven 
here? Does SUB1 play a role in parasite 
egress at other points in the life cycle, 
for example liver-stage merozoite exit 
or sporozoite release from oocysts in 
the mosquito vector? Interestingly, 
another member of the SERA family, 
the ortholog of PfSERA8, is essential 
for sporozoite release from oocysts in 
the rodent malaria parasite, Plasmo-
dium berghei (Aly and Matuschewski, 
2005). Are there more substrate strings 
to the PfSUB1 bow, and are merozo-
ite proteins themselves also targeted 
by PfSUB1 to perhaps promote the 
invasive ability of the merozoite? The 
primary processing agent for several 
merozoite surface proteins (such as 
MSP1, 3, 5, and 6) is unclear and may 
involve SUB1.
In terms of the value of SUB1 as a 
therapeutic target, it is worrying that 
the IC50 established for their recom-7 Elsevier Inc.binant PfSUB1 inhibitor MRT12113 
soars when tested on parasites. In 
part, this decrease in efficacy might 
be due to accessibility, but it highlights 
the need for improved inhibitors. Suc-
cessful screens may be informed by 
more information about the biology 
of SUB1 and its substrates. A multi-
substrate protease, in principle and 
as shown with studies on HIV pro-
tease (reviewed in Louis et al., 2007), 
is an excellent drug target, because 
the likelihood of compensatory muta-
tions in both the protease active site 
and the substrate cleavage site that 
might result in drug resistance is low. 
Clearly the tip of a large iceberg has 
been discovered, and we can antici-
pate an abundance of fundamental 
discoveries that will only strengthen 
the biologists’ armory in the search 
for therapies against the pernicious 
diseases caused by Plasmodium and 
other apicomplexans.
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